• Latest Posts

Hemophilia drug from Sanofi and Sobi has license application accepted for priority review by FDA

More News! 22 Nov 2018

First Drug for Rare Inflammation Syndrome Approved by FDA

Swedish Biotech Can Now Fast-Track its Metabolic Disorder Drug

Rare Disease Biopharma can now sell Hemophilia treatment across whole of EU

French Ipsen closes €700M deal for Californian Cancer Drug


Global Hemophilia AID project achieves first milestone with donations from Swedish Biotech

What happened this week? Biotech revolutionizes Coffee, Paris N°1 Biocluster, a DNA-made Computer…